about
Improved assays for determining the cytosolic access of peptides, proteins, and their mimetics.LDGIdb: a database of gene interactions inferred from long-range strong linkage disequilibrium between pairs of SNPs.Contextual data integration in drug discovery.Peptides that inhibit HIV-1 integrase by blocking its protein-protein interactions.Peptides and peptidomimetics as immunomodulators.Biomolecular Interactions of small-molecule inhibitors affecting the YopH protein tyrosine phosphatase.Stability of structured Kaposi's sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization.Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space.Targeting protein-protein interfaces using macrocyclic peptides.Medicinal chemistry for 2020Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7.Structure-activity relationships of peptidomimetics that inhibit PPI of HER2-HER3.On the binding affinity of macromolecular interactions: daring to ask why proteins interact.Review cyclic peptides on a merry-go-round; towards drug design.Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides.A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides.Small molecule probes to target the human Mediator complex.Identifying protein-protein interaction sites using peptide arrays.Developing potent backbone cyclic peptides bearing the shared epitope sequence as rheumatoid arthritis drug-leads.Development of a multipurpose scaffold for the display of peptide loops.Mapping the interaction site and effect of the Siglec-9 inflammatory biomarker on human primary amine oxidase.Prediction and interpretation of the lipophilicity of small peptides.Model peptide studies of Ag+ binding sites from the silver resistance protein SilE.CD and NMR conformational studies of a peptide encompassing the Mid Loop interface of Ship2-Sam.
P2860
Q33553611-77D5E626-C45C-4A98-A5F1-E16982835ED6Q34253535-BD3DC7CD-A7BA-4EE3-BB5F-9341873F128DQ34289560-5EAC665A-EE08-4216-8FB7-AD370E4B5F45Q34320018-46CB8E96-F3B5-4841-987F-250E3BF4BE29Q34359984-6CE0BE5C-7214-4852-9244-0681F22ABAE4Q34513199-06828D00-C435-44C0-81BF-B660561D9279Q35111060-AFE7A26F-4A5D-4CC6-87D5-DB2B5EBA931CQ35158672-FAED4FE6-9EF7-4938-8BB3-11504C48F60EQ35558196-CFB41C94-BA0D-4F39-B012-D7C46023B630Q35593223-D6E8F4E0-D643-402C-AE37-EEA2C3B6C16BQ36964946-C876B4AB-B841-4E0C-ACF8-F14DF50C86EDQ37721805-3B439DF8-1B63-494B-AC04-712644257272Q38067023-30B202C4-DA15-4CE6-89C6-6056D241A3A3Q38476515-13917F8B-C617-4619-874D-980AB26CC5C2Q38524164-8E15A576-52A8-43C0-B7B0-9BEF0723A32EQ39953670-A91846A2-97C6-49AC-86B8-72802730C837Q41370397-A929FEC7-2036-4914-95F1-B20B9205F629Q41915395-6A91DFBC-C1BB-49A9-B167-0D2C8507104CQ43240960-62304C9B-FA51-4217-AFD5-D38D263B51D1Q48505189-53D540E5-4F2E-4E2F-B85C-94BEC13F8089Q49389522-03580DF7-F80C-4189-B074-E62C9F672F35Q50978597-112EB829-87C8-4558-A8EE-7ED94CA4244DQ50989040-13D273D4-C0C7-47F7-9C6E-DDC7CB171B28Q54348199-8AA407C5-68DF-4B26-96CF-891E99B34C7B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Using peptides to study protein-protein interactions.
@en
Using peptides to study protein-protein interactions.
@nl
type
label
Using peptides to study protein-protein interactions.
@en
Using peptides to study protein-protein interactions.
@nl
prefLabel
Using peptides to study protein-protein interactions.
@en
Using peptides to study protein-protein interactions.
@nl
P2860
P356
P1476
Using peptides to study protein-protein interactions.
@en
P2093
Assaf Friedler
Hadar Benyamini
P2860
P304
P356
10.4155/FMC.10.196
P577
2010-06-01T00:00:00Z